AVNT vs MRNA · P/E 32, rev $1.76B vs rev $145.0M
Avient Corp (AVNT) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Avient Corp (AVNT) is a specialty chemicals company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported AVNT revenue for 2026-06-30 was $1.76B. Net income was $120.5M. AVNT currently screens at market cap $3.13B and trailing P/E 31.7.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
AVNT currently screens at market cap $3.13B and trailing P/E 31.7. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the AVNT and MRNA stock pages for the full models.
Not investment advice.